v3.25.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Private Placement
Common Stock
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2023     41,205,551          
Beginning balance, amount at Dec. 31, 2023 $ 405,386   $ 41   $ 550,491     $ (145,146)
Exchange of common stock for pre-funded warrants, shares     (1,842,499)          
Exchange of common stock for pre-funded warrants, value (25)   $ (2)   (23)      
Exercise of stock options, shares     5,595          
Exercise of stock options, amount 26       26      
Vesting of restricted stock awards 11       11      
Stock-based compensation 3,904       3,904      
Net loss (35,811)             (35,811)
Other comprehensive loss (279)           $ (279)  
Ending balance, shares at Mar. 31, 2024     39,368,647          
Ending balance, amount at Mar. 31, 2024 373,212   $ 39   554,409   (279) (180,957)
Beginning balance, shares at Dec. 31, 2023     41,205,551          
Beginning balance, amount at Dec. 31, 2023 405,386   $ 41   550,491     (145,146)
Net loss (80,159)              
Ending balance, shares at Jun. 30, 2024     45,862,391          
Ending balance, amount at Jun. 30, 2024 436,101   $ 46   661,683   (323) (225,305)
Beginning balance, shares at Mar. 31, 2024     39,368,647          
Beginning balance, amount at Mar. 31, 2024 373,212   $ 39   554,409   (279) (180,957)
Issuance of common stock in private placement, net of issuance costs, amount   $ 102,888   $ 7   $ 102,881    
Issuance of common stock in private placement, net of issuance costs, shares       6,471,000        
Exercise of stock options, shares     22,744          
Exercise of stock options, amount 80       80      
Vesting of restricted stock awards 11       11      
Stock-based compensation 4,302       4,302      
Net loss (44,348)             (44,348)
Other comprehensive loss (44)           (44)  
Ending balance, shares at Jun. 30, 2024     45,862,391          
Ending balance, amount at Jun. 30, 2024 436,101   $ 46   661,683   (323) (225,305)
Beginning balance, shares at Dec. 31, 2024     46,042,504          
Beginning balance, amount at Dec. 31, 2024 360,229   $ 46   672,540   291 (312,648)
Exercise of stock options, shares     12,447          
Exercise of stock options, amount 38       38      
Vesting of restricted stock awards 7       7      
Stock-based compensation 6,876       6,876      
Net loss (84,498)             (84,498)
Other comprehensive loss (195)           (195)  
Ending balance, shares at Mar. 31, 2025     46,054,951          
Ending balance, amount at Mar. 31, 2025 282,457   $ 46   679,461   96 (397,146)
Beginning balance, shares at Dec. 31, 2024     46,042,504          
Beginning balance, amount at Dec. 31, 2024 $ 360,229   $ 46   672,540   291 (312,648)
Exercise of stock options, shares 17,478              
Net loss $ (134,435)              
Ending balance, shares at Jun. 30, 2025     46,498,896          
Ending balance, amount at Jun. 30, 2025 237,697   $ 46   684,743   (9) (447,083)
Beginning balance, shares at Mar. 31, 2025     46,054,951          
Beginning balance, amount at Mar. 31, 2025 282,457   $ 46   679,461   96 (397,146)
Exercise of stock options, shares     5,031          
Exercise of stock options, amount 5       5      
Vesting of restricted stock units, shares     438,914          
Vesting of restricted stock awards 19       19      
Stock-based compensation 5,258       5,258      
Net loss (49,937)             (49,937)
Other comprehensive loss (105)           (105)  
Ending balance, shares at Jun. 30, 2025     46,498,896          
Ending balance, amount at Jun. 30, 2025 $ 237,697   $ 46   $ 684,743   $ (9) $ (447,083)